Abstract
Biofabrication can be a tool to three-dimensionally (3D) print muscle cells embedded inside hydrogel biomaterials, ultimately aiming to mimic the complexity of the native muscle tissue and to create in-vitro muscle analogues for advanced repair therapies and drug testing. However, to 3D print muscle analogues of high cell alignment and synchronous contraction, the effect of biofabrication process parameters on myoblast growth has to be understood. A suitable biomaterial matrix is required to provide 3D printability as well as matrix degradation to create space for cell proliferation, matrix remodelling capacity, and cell differentiation. We demonstrate that by the proper selection of nozzle size and extrusion pressure, the shear stress during extrusion-bioprinting of mouse myoblast cells (C2C12) can achieve cell orientation when using oxidized alginate-gelatin (ADA-GEL) hydrogel bionk. The cells grow in the direction of printing, migrate to the hydrogel surface over time, and differentiate into ordered myotube segments in areas of high cell density. Together, our results show that ADA-GEL hydrogel can be a simple and cost-efficient biodegradable bioink that allows the successful 3D bioprinting and cultivation of C2C12 cells in-vitro to study muscle engineering.
Highlights
Besides cardiac and smooth muscle, skeletal muscle is one of the three types of vertebrae muscles [1]
We demonstrate that it is possible to influence the alignment of C2C12 cells in 3D printed achieve cell orientation when using oxidized alginate-gelatin (ADA-GEL) hydrogel constructs by altering processing parameters, which has an effect on the proliferation of C2C12 over time in ADA-GEL hydrogels
We demonstrated that ADA-GEL hydrogel is a promising biomaterial for 3D cell growth of C2C12 myoblasts
Summary
Besides cardiac and smooth muscle, skeletal muscle is one of the three types of vertebrae muscles [1]. Common clinical strategies to treat diseased and injured skeletal muscle are either free muscle transfer, the use of advanced braces [7, 11, 12], or myogenic stem cell transplantation, which involves the use of radiation and the administering of toxic myeloablative drugs [5]. Despite technological advances, those methods rarely allow to fully restore muscle function or involve clinical procedures of high risk for patient health [7, 13]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.